31.9 C
Vientiane
Friday, September 12, 2025
spot_img
Home Blog Page 153

NYSE Content advisory: Pre-Market update + Investors Digest Nvidia’s Latest Earnings

NEW YORK, Aug. 28, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

 

Ashley Mastronardi delivers the pre-market update on August 28th

  • Investors Digest Nvidia’s Q2 earnings
  • The S&P 500 is coming off a record close
  • GDP and weekly jobless claims data out before market open

Opening Bell
Energy Council celebrates the New York Energy Capital Assembly conference and all of NYSE’s energy issuers

Closing Bell
YTexas celebrates its 5th annual summit, which aims to assist high-growth organizations accelerate their presence in Texas

Click here to download the NYSE TV App

 

Vietnam’s Global Aspirations on Display at Hanoi’s New Vietnam Exposition Center

The launch of Vietnam Exposition Center has affirmed its status as Hanoi’s newest architectural icon, while also highlighting Vietnam’s rising position on the global map of preferred destinations for global events.


HANOI, VIETNAM – Media OutReach Newswire – 28 August 2025People from all over Vietnam flocked to the Center in Đông Anh District to attend the exhibition “80 Years of Independence – Freedom – Happiness.” The event brought Vietnam’s history, its people, and recent achievements to life, drawing tens of thousands of visitors in the opening week.

The Vietnam Exposition Center in Hanoi, Vietnam.
The Vietnam Exposition Center in Hanoi, Vietnam.

Much of this appeal comes from the Center’s unique role – not only is it the largest facility of its kind in Southeast Asia, covering nearly 90 hectares, but it also stands as a proud symbol of Vietnam, a nation that endured decades of war and hardship yet has risen to remarkable growth throughout this historic journey.

Beyond its impressive scale and modern architecture, the Center embodies Vietnam’s aspirations for international integration and innovation. It signals an openness to hosting world-class conferences, exhibitions, and cultural events – helping fuel Vietnam’s MICE (Meetings, Incentives, Conferences, Exhibitions) tourism sector and growing cultural industries. Notably, it also carries the mark of Vingroup, the largest private conglomerate in Vietnam, which envisions the Center not only as an iconic landmark, but also as a “bridge” connecting Vietnamese enterprises with the global business community through world-class exhibitions and trade fairs.

The journey to build this modern infrastructure for the capital began with the Prime Minister’s approval in 2015, with the goal of meeting the demand for large-scale events. The site was strategically chosen at the northeastern gateway of Hanoi, providing easy access to Nội Bài International Airport and major transportation routes – making it convenient for both domestic and international guests.

The importance of this location is further underscored by the upcoming launch of the Tu Lien Bridge – a key infrastructure project spanning the Red River – which will provide a fast connection between the city center and the exhibition complex. This will give the Center a major advantage in terms of accessibility, making it a convenient destination for large-scale national and international events.

One distinctive aspect of the project is its blend of tradition and modernity. The Center stands on land closely tied to the ancient Co Loa Citadel, a historic site associated with legends of Vietnam’s founding and defense. In just over 10 months of accelerated construction – cutting the original timeline in half – a striking 24,000-ton steel dome was completed, marking new standards for Vietnam’s construction industry and a spirit of innovation in infrastructure development.

A particular highlight is the Kim Quy Exhibition Hall, with its flowing dome inspired by the legendary “Golden Turtle” (Kim Quy) of Vietnamese folklore. The spiral pattern on the dome, along with expansive plazas, parks, and outdoor exhibition areas, gives the complex a distinctive identity that weaves together tradition and contemporary creativity.

“The sheer scale and modernity of this space convince me that Vietnam is ready to host major international events,” shared a young entrepreneur attending the opening.

Technology products of Vingroup such as VinRobotics and VinMotion at the the exhibition.
Technology products of Vingroup such as VinRobotics and VinMotion at the the exhibition.


A New Engine for Vietnam’s Event Economy

The significance of the Vietnam Exposition Centergoes far beyond symbolism. Its launch aligns with the global rise of the events industry, which is increasingly seen as a powerful driver of economic growth in many countries. According to the Global Association of the Exhibition Industry (UFI), each dollar spent at exhibitions can generate two to three times that value through related services – accommodation, transportation, trade, and national branding¹.

For example, the 2010 Shanghai World Expo drew 73 million visitors and generated nearly $2 billion in revenue over just six months². Dubai’s Expo 2020 attracted over 24 million visitors, contributed an estimated $42 billion to the UAE economy (2013 to 2042), and created tens of thousands of new jobs³. And the global market for events and exhibitions is forecast to keep growing, reaching an estimated $63.75 billion by 2029⁴.

That Vingroup has invested in and completed an international-standard exhibition center in Đông Anh demonstrates a vision of global integration. This achievement brings Vietnam in line with global trends, drives the growth of creative industries, culture, and high-quality services, and attracts additional international investment.

This project is expected to welcome up to 60 million visitors each year to Hanoi – a hub for entertainment, arts, business, and global networking. The arrival of the Vietnam Exposition Centeris helping Vietnam steadily secure its place on the regional events map, opening a new chapter of development, connection, and integration.

Hashtag: #Vingroup

The issuer is solely responsible for the content of this announcement.

PixVerse Launches AI Video Model V5 With Free Access Week

SINGAPORE, Aug. 28, 2025 /PRNewswire/ — AI video platform PixVerse has launched its latest generation model, PixVerse V5, alongside a new Agent feature designed to make video creation easier for everyday users. The company also announced that its global user base has surpassed 100 million.

To mark the launch, PixVerse is offering free access to V5 for a limited time:

  • Start:Aug 28, 2025 – 00:00 (Pacific Time, UTC−7)
  • End:Sep 1, 2025 – 00:00 (Pacific Time, UTC−7)

Key Enhancements in PixVerse V5

V5 introduces significant enhancements across several dimensions of video generation:

  • Motion Quality: More natural and expressive movements, with smoother and more coherent trajectories.
  • Visual Performance: Sharper resolution, richer details, realistic textures, improved lighting for a cinematic finish.
  • Consistency: Stable style, color, and lighting across frames and scenes.
  • Prompt Accuracy: Closer alignment with user prompts, including characters, styles, and environments.

Despite these upgrades, V5 maintains high speed and accessibility. Users can generate a 360p video in 5 seconds or a 1080p video in about one minute, making video creation faster and more accessible — from instant social sharing to cinematic and professional use.

PixVerse Agent: Simple Video Creation for All
By uploading a single photo and choosing an agent, users can automatically generate a 5–30 second clip—turning everyday images into short stories, memes, or creative edits. The tool lowers the barrier to entry, making video generation practical not only for professionals but also for casual users.

PixVerse V5 and the Agent feature are available across the web, mobile apps, and open API platforms.

Global Adoption and Impact

PixVerse now serves more than 100 million users worldwide, who have collectively produced over 800 million videos. The platform’s viral Venom Effect template launched with PixVerse V3 has alone generated more than one billion views on social media, amplified by participation from celebrities and influencers.

These milestones highlight how AI-powered video creation is spreading beyond niche creators to mainstream audiences. PixVerse V5 and Agent extend professional-quality video tools to broader communities, supporting applications in advertising, e-commerce, gaming, education, and entertainment.

PixVerse V5 debuted strongly on independent benchmarks, placing 2nd in image-to-video and 3rd in text-to-video rankings by Artificial Analysis. The platform also ranked 25th on a16z’s Top 50 Gen AI Consumer Apps, reinforcing its growing influence in the global AI ecosystem.

#AI for Good

In 2025, PixVerse was recognized at the UN AI for Good Global Summit. It later launched the #AIForGood Short Film Contest, which attracted over 100 submissions in its first month, highlighting themes from environmental protection to social equality.

About PixVerse:

PixVerse is a generative AI video platform that is transforming the way digital content is created. With its intuitive, one-click video generation, users can create cinematic-quality videos from simple inputs, such as a video, a photo or a line of text—no prior production knowledge required. PixVerse has experienced remarkable growth, with its global user base surpassing 100 million in August 2025. Monthly active users have exceeded 16 million. The platform has launched in 13 languages, reaching users across more than 175 countries and regions.

For more information visit: https://pixverse.ai/ 

Contact for the press Enna Jin

media@pixverse.ai 

Bairong Inc. Announces 2025 Interim Financial Results

Revenue Grows Rapidly with Year-on-Year Increase in Net Profit Margin

BEIJING, Aug. 28, 2025 /PRNewswire/ — Bairong Inc. (the “Company”, “we” , “us” or “our” ; HKEX: 6608), a leading cloud-based AI turnkey service provider, today announced the interim results of the Group for the six months ended June 30, 2025.

Mr. Zhang Shaofeng, Founder, Chief Executive Officer and Chairman of the Board, commented:
“In the first half of 2025, the Company achieved a year-on-year revenue growth of 22% while maintaining sustained profitability. The revenue of our MaaS business increased by 19% year-on-year. Our BaaS business also achieved rapid growth, especially the revenue of the BaaS financial industry cloud driven by generative AI, which surged by 45% year-on-year. Our gross profit remained strong at over 70% while non-IFRS profit for the period reached 254 million, with a non-IFRS net profit margin of 16%. This demonstrates that our investments in the AI business have not only brought first-mover advantages but also achieved meaningful economies of scale. In terms of technology and products, relying on the intelligent voice product VoiceGPT and the Bairong enterprise-level intelligent agent platform CybotStar, we have deeply integrated our cross-industry AI capabilities into high-potential sectors such as telecom operators, medical care, and large-scale retail. Notably, the commercialization of the Bairong CybotStar enterprise-level intelligent agent platform has been commercialized.”

Financial Summary

Six months ended June 30,

2025

2024

Change

(unaudited)

(unaudited)

( %)

(RMB in thousands, except percentages)

Revenue

1,611,797

1,321,348

22

 Model as a service (“MaaS“)

501,941

421,352

19

 Business as a service (“BaaS“)

1,109,856

899,996

23

  BaaS – Financial Scenario

856,957

589,473

45

  BaaS – Insurance Scenario

252,899

310,523

-19

Gross profit

1,182,428

967,155

22

Operating profit

200,894

156,832

28

Profit for the period

201,224

142,833

41

Non-IFRS measures

Non-IFRS profit for the period

254,449

197,479

29

Non-IFRS EBITDA

282,539

243,481

16

Revenue 

For the six months ended June 30, 2025, our revenue reached RMB1,611.80 million, representing a period-over-period increase of 22% from RMB1,321.35 million for the six months ended June 30, 2024. During the Reporting Period, our non-IFRS profit was RMB 254.45million and our non-IFRS profit margin remained healthy at 16%, representing a period-over-period increase of 1 percentage point.

For the six months ended June 30, 2025, our MaaS business reported revenue of RMB 501.94million, representing an increase of 19% period-over-period, primarily attributable to expanded fields of application and enhanced product competitiveness combining AI algorithms to optimize product performance. During the Reporting Period, the number of Key Clients reached 167, while average revenue per Key Client was RMB 2.28 million. Our Key Client retention rate was 98%.

Key metrics of MaaS

Six months ended June 30,

2025

2024

Change

(unaudited)

(unaudited)

( %)

(RMB in thousands, except percentages)

Revenue from MaaS

501,941

421,352

19

 Revenue from Key Clients(Note)

380,534

329,398

16

  Number of Key Clients

167

165

1

  Average revenue per Key Client

2,279

1,996

14

Retention rate of Key Clients

98 %

96 %

2 pp

Note: Key Clients” are defined as paying clients that each contributes more than RMB300,000 total
revenue to the Company year-to-date.

For the six months ended June 30, 2025, our BaaS – Financial Scenario business reported revenue of RMB 856.96million, representing a year-over-year increase of 45% from RMB589.47 million for the six months ended June 30, 2024.In the first half of 2025, following the algorithm registration of our enterprise-grade agent platform, CybotStar, our proprietary large language model, BR-LLM, has now also completed registration as a national large-model. Leveraging BR-LLM, we have launched a comprehensive suite of AI products, including CybotStar, Digital Humans, VoiceGPT intelligent voice capabilities, and others. This forms a complete AI product ecosystem, creating a commercial closed loop from customized foundational models and mid-layer agent development to final solution delivery. As AI integration deepens across application scenarios, our BaaS Financial Scenario continues to capitalize on its strengths in scenario-driven AI to achieve breakthroughs in multiple sectors.

Key metrics of BaaS – Financial Scenario

Six months ended June 30,

2025

2024

Change

(unaudited)

(unaudited)

( %)

(RMB in thousands, except percentages)

Revenue from BaaS – Financial Scenario

856,957

589,473

45

In the first half of 2025, our BaaS – Insurance Scenario revenue decreased by 19% period-over-period to RMB 252.90million. Total premiums increased by 9% period-over-period to RMB 3,118.79million. In the first half of 2025, first year premiums increased by 5% period-over-period to RMB 2,006.15million. Renewal premiums increased by 15% period-over-period to RMB 1,112.64million. The persistency rate of life insurance premiums continued to exceed 90%, ranking among the top in the industry.

Key metrics of BaaS – Insurance Scenario

Six months ended June 30,

2025

2024

Change

(unaudited)

(unaudited)

( %)

(RMB in thousands, except percentages)

Revenue from BaaS – Insurance Scenario

252,899

310,523

(19)

 Revenue from first year premiums

203,963

254,658

(20)

  First year premiums

2,006,151

1,904,544

5

 Revenue from renewal premiums

48,936

55,865

(12)

  Renewal premiums

1,112,639

968,119

15

Cost of sales

Our cost of sales increased by 21% from RMB354.19 million for the six months ended June 30, 2024 to RMB429.37 million for the six months ended June 30, 2025, in line with the growth of our business scale.

Gross profit and gross margin

As a result of the foregoing, the Group’s gross profit increased by 22% from RMB967.16 million for the six months ended June 30, 2024 to RMB1,182.43 million for the six months ended June 30, 2025. The Group’s gross margin remained stable at 73%.

Research and development expenses

The Group’s research and development expenses increased by 33% from RMB225.88 million for the six months ended June 30, 2024 to RMB301.54 million for the six months ended June 30, 2025, primarily attributable to the increased investments at corporate level for AI. Research and development expenses as a percentage of revenue increased by 2pct to 19%.

General and administrative expenses

The Group’s general and administrative expenses were RMB140.21 million and RMB139.94 million for the six months ended June 30, 2025 and 2024, respectively, which remained stable on a period-over-period basis.

Sales and marketing expenses

Our sales and marketing expenses increased by 20% from RMB506.54 million for the six months ended June 30, 2024 to RMB606.28 million for the six months ended June 30, 2025, primarily due to an increase of RMB116.07 million in information technology services, promotion, advertising and other related expenses, which was mainly due to our continuous efforts to efficiently reach and engage users to improve conversion efficiency and the increased branding and business promotion to enhance our brand recognition.

Other income

Our net other income increased by 15% from RMB73.03 million for the six months ended June 30, 2024 to RMB83.75 million for the six months ended June 30, 2025. This is primarily due to the increase of RMB22.86 million in net gains on disposal of subsidiaries, partly offset by the increase in foreign exchange losses arising from depreciation of USD against RMB.

Profit for the year

As a result of the foregoing, the Group’s profit for the period increased from RMB142.83 million for the six months ended June 30, 2024 to RMB201.22 million for the six months ended June 30, 2025.

Cash, cash equivalents and time deposits

The Group had cash and cash equivalents of RMB833.52 million and cash reserve of RMB2,895.78 million as at June 30, 2025, compared to the balance of RMB739.23 million and RMB2,917.94 million as of December 31, 2024, respectively. The cash reserve included restricted cash, time deposits and treasury investments. During the six months ended June 30, 2025, the Company repurchased a total of 3,274,500 Class B Shares (the “Shares Repurchased”) on the Stock Exchange at an aggregate consideration (including transaction cost) of approximately HK$[25.78] million including expenses to enhance the Company’s shareholder value in the long run.

Conference Call

Our management will hold a conference call at 9:00a.m. Beijing / Hong Kong Time on Friday, August 29, 2025 to discuss the financial results and answer questions from investors and analysts.

For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time.

Participant Online Registration:
https://webcast.roadshowchina.cn/kxb22E/meet

Dial-in details for the earnings conference call are as follows:

International: +86-23-62737100
Mainland China: 023-63623333/4008-063-263
HK China: +852-30183602/+800-961505

English Dial-in Password: 649518155
Chinese Dial-in Password: 320556788

Please scan the QR code in the poster below to register for the conference:


About Bairong Inc.

Bairong Inc. is a leading artificial intelligence (AI) technology services company. The Company applies natural language processing (NLP), privacy computing, machine learning, cloud computing and other technologies to provide services to enterprises through model-as-a-service (MaaS) and business-as-a-service (BaaS). The MaaS services leverage discriminant AI to digitalize the know-your-customer (KYC) and know-your-product (KYP) process for enterprises, by analyzing users’ risk, willingness, and capability. The BaaS services use discriminant AI to analyze and stratify users into groups and develops generative AI-powered VoiceGPT using human natural languages to interact with users. The Company’s products and services are widely used by enterprise customers in banking, consumer finance, insurance, e-commerce, automobiles, logistics, ticketing, energy, construction and other industries.

For more information, please visit: http://ir.brgroup.com

Safe Harbor Statement

This press release contains statements that may constitute “forward-looking” statements. These forward-looking statements can be identified by terminologies such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “likely to,” and the negative of these words and other similar expressions or statements. Bairong may also make written or oral forward-looking statements in its periodic reports to the HKEx, in its annual and interim reports to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties. Statements that are not historical facts, including statements about Bairong’s beliefs, plans, and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statements, including but not limited to the following: Bairong’s strategies, future business development, and financial condition and results of operations; Bairong’s limited operating history; risks associated with the financial service industry, Bairong’s ability to develop and deliver services of high quality and appeal to clients; Bairong’s ability to generate positive cash flow and profits; Bairong’s ability to compete successfully; Bairong’s ability to build its brand and withstand negative publicity; and changes in client demand and government incentives, subsidies, or other favorable government policies. Further information regarding these and other risks is included in Bairong’s filings with the HKEX. All information provided in this press release is as of the date of this press release, and Bairong does not undertake any obligation to update any forward-looking statements, except as required under applicable laws.

For investor inquiries, please contact:
Bairong Inc.
Ms. Sandy Qin, CFA, CMA, FCG HKFCG
Email: ir@brgroup.com

For media inquiries, please contact:
Bairong Inc.
Email: brmarketing@brgroup.com

AIP Capital and BeYoke Capital Form Strategic Partnership

AIP Capital and BeYoke have formed a strategic partnership to originate aircraft and engine investment opportunities for Japanese investors

DUBLIN and STAMFORD, Conn. and TOKYO, Aug. 28, 2025 /PRNewswire/ — AIP Capital (“AIP”), an alternative investment manager focused on opportunities in asset-based finance and BeYoke Capital (“BeYoke”), a global aviation specialty investment platform based in Japan, today announced the formation of a strategic partnership.

BeYoke
BeYoke

The partnership will originate aircraft and engine investment opportunities for Japanese investors via Japanese Operating Lease (“JOL”), Japanese Operating Lease with Call Option (“JOLCO”) structures, and secured loan products. As part of this partnership, AIP has made a minority investment in BeYoke and would join the board of directors. This positions AIP with a Japanese FSA licensed JOL / JOLCO arrangement platform and will go on to further expand AIP’s presence in the Asia-Pacific region.

“We are excited to formally begin this partnership with BeYoke,” said Scott Debano, Managing Director at AIP. “BeYoke is led by a team of experienced and well-respected market leaders. AIP and BeYoke are well aligned with a similar vision, and we believe this partnership will bolster both platforms while enhancing AIP’s financing capabilities and further grow our investor base and serve our airline customers across the globe.”

“We are pleased to announce this partnership to the market,” said Rion Sato, CEO of BeYoke Capital. “AIP has proven its capabilities as an origination partner and asset manager. We believe our shared core values and principles will enable us to deliver innovative solutions that align with the evolving needs of our airline partners and unlock diverse and creative investment opportunities for our investors.”

AIP Capital was advised by Morgan Lewis as lead counsel and KPMG on tax structuring.

About AIP Capital

AIP Capital (AIP) is a global alternative investment manager focused on opportunities in asset-based finance including aviation and equipment finance. AIP, together with its affiliates, manages approximately $4 billion of assets on behalf of a diversified global investor base. The AIP team is comprised of more than 40 experienced professionals across AIP’s offices in Stamford, New York City, Dublin, and Singapore.

For more information about AIP Capital or to speak with company executives, please contact investor.relations@aipcapital.com.

About BeYoke Capital

Established in 2021, BeYoke Capital (BeYoke) is an FSA-registered financial service provider that aims to build a global specialty investment platform for aviation assets. BeYoke was founded by a team of professionals with deep knowledge and experience in aviation and structured finance. BeYoke is committed to its core mission of creatively bridging the gap between global airlines with growing funding needs and investors seeking diverse opportunities.

For more information about BeYoke Capital or to speak with company executives, please contact info@beyoke.com.

Media Contact

AIP Capital
Geoffrey Bayers
investor.relations@aipcapital.com

BeYoke Capital
Kazuya Kurita
info@beyoke.com

 

Uni-Bio Science Group Announces 2025 Interim Results

EPS Surged to 1.27 HK Cents with a Three-year CAGR of 43.1%, Robust Revenue Growth Driven by Strong Demand for Bogutai® and Omnichannel Strategy


HONG KONG SAR – EQS Newswire – 28 August 2025 – A fully integrated biopharmaceutical company – Uni-Bio Science Group Limited (“Uni-Bio Science”, together with its subsidiaries referred to as the “Group”, stock code: 0690.HK), is pleased to announce its interim results for the six months ended 30 June 2025 (the “Period”).

Key Accomplishments in the First Half of 2025

During the Period, the Group achieved a spectrum of accomplishments, for both of its marketed products and innovative biologics. The key highlights include:

1. During the Period, the Group delivered solid financial results, with revenue achieved an increase of 13.4% year-on-year (“YoY”) and net profit reaching a record HK$76.0 million, up 12.7% YoY, while EPS increased from HK$0.62 cents in the first half of 2023 to HK$1.27 cents in the first half of 2025, representing a three-year CAGR of 43.1%. The growth this year was driven by the Group’s omnichannel strategy and increasing demand for Bogutai®, along with in the Group’s existing marketed drugs. Meanwhile, the Group strengthened its financial position, with improvements across all key liquidity ratios and overall financial resilience.
2. Since its official launch in March 2024, Bogutai® has steadily built market recognition and sustained growth momentum. Bogutai® has achieved solid progress in clinical uptake and patient enrollment, with over 8,000 new patients and 6,000 returning patients, and establishing a broad and in-depth market network across first- to fourth-tier markets. During the Period, revenue of Bogutai® increased substantially from approximately HK$18.8 million to approximately HK$65.6 million, representing a significant increase of 248.9%.
3. In May 2025, the Group’s second ophthalmology product, 金因康® (Diquafosol Sodium Eye Drops), received marketing approval from the China National Medical Products Administration (“NMPA”), marking a significant milestone in expanding the Group’s ophthalmic portfolio.
4. In July 2025, the marketing application of Isavuconazonium sulfoate capsules was officially accepted by the NMPA, marking a significant milestone for the Group in the field of antifungal treatment. Isavuconazonium sulfoate capsules is expected to be approved for launch in the second half of 2026.
5. In June 2025, the Group officially launched the high-end series GeneQueens™ of 肌顏態® and the medical device brand 金因敷®, marking a key milestone in its strategic expansion into the integrated “Drug, Medical Device, and Aesthetics” field.
6. During the Period, the Group is refocusing its R&D strategy on regenerative medicine. In particular, the Group is in discussions with leading regenerative medicine research institutions in China to establish industry–academic partnerships in this field, aiming to co-develop innovative therapies leveraging growth factors and regenerative medicine technologies, combining complementary strengths to accelerate research and further strengthen the Group’s leadership in biopharmaceutical innovation.

Interim Results

For the Period, the Group recorded revenue of approximately HK$310.2 million, representing an increase of 13.4% YoY. Revenue of Bogutai® increased substantially from approximately HK$18.8 million to approximately HK$65.6 million, representing a significant increase of 248.9%. Revenue generated from GeneTime® was approximately HK$107.8 million, representing an increase of 18.1% YoY. GeneSoft® recorded a mild decrease in revenue to approximately HK$18.5 million, representing a decrease of 2.1% YoY. Currently, the Group is preparing for GeneSoft® entry into medical insurance coverage, aiming for inclusion by the end of 2025, and providing a strong catalyst for future growth. Pinup® recorded a decrease of 22.7% in revenue to approximately HK$108.9 million for the Period. The Group was re-selected for the centralized procurement in 2024, with a validity period of two years. However, in response to certain local policy changes, the Group adopted a more selective approach to hospital supply. Hospitals in many provinces began procuring Boshutai® in 2025. Revenue from Boshutai® was approximately HK$6.1 million, representing a significant increase of 84.8%.
Gross profit was approximately HK$254.1 million, representing an increase of 10.2% YoY, whereas gross profit margin was 81.9% (first half of 2024:84.3%). The decrease in gross profit margin was primarily due to the recent addition of Bogutai®, which is still in the early stages of commercialization and had a relatively low output volume, resulting in higher product costs. Profit for the Period surged from approximately HK$67.4 million in the first half of 2024 to approximately HK$76.0 million, representing an increase of 12.7%. This result reflects the effectiveness of the Group’s strategic focus on operational efficiency, disciplined cost control, and targeted commercial execution, reinforcing its trajectory toward sustained profit growth and long-term value creation. The earnings per share reached approximately HK$1.27 cents, reflecting a growth of 16.5% YoY.

Prospects

China’s medical device industry is expected to grow at an 8.9% CAGR from 2023 to 2030, fueled by rising chronic diseases and innovation investment. Government policies like “Made in China 2025” and the 2025 “Measures to Support High-Quality Development of Innovative Drugs” promote drug innovation, expanded insurance, faster approvals, and prioritize key therapies, including pediatric, chronic, and infectious diseases. National procurement now favors innovation over price, supporting sustainable healthcare growth. Leveraging advanced synthetic biology, the Group is well-positioned to seize these opportunities and advance regenerative therapies in orthopedics, ophthalmology, dermatology, and medical aesthetics.
Looking forward, Mr. Kingsley Leung, Chairman of Uni-Bio Science said, “We are committed to pursuing a diversification strategy to ensure sustainability by driving product innovation and expanding marketing channels and geographical presence. During the Period, we achieved notable breakthroughs in our product portfolio. We received marketing approval of our new ophthalmology product, 金因康®, and antifungal product, isavuconazonium sulfoate capsules. Our medical aesthetic products also experienced a major launch with the introduction of the high-end GeneQueens™ series, along with a new medical device brand, 金因敷®.
We have implemented omnichannel strategies to broaden our customer base beyond traditional hospital networks. Our direct sales team works closely with multiple-tier hospitals, while our own flagship stores are established on all major Chinese online sales platforms. We will continue to grow our online presence and expand our distributor network to support offline marketing. Internationally, we are focusing on markets such as the U.S., Middle East, and Southeast Asia. Our FDA application for Bogutai® is progressing, with approval expected as early as 2027, targeting it as our first overseas commercial product.
During the Period, we further re-focused our R&D strategy in regenerative medicine. To enhance our core strengths and enter advanced therapies, we established two cutting-edge R&D platforms: the ECO-KSFA® Mini-protein Superfactory, which enables large-scale production of complex-structured polypeptides while significantly reducing costs; and the Biological Hydrogel Technology Platform, designed to incorporate active molecules such as growth factors for enhanced tissue engineering repair. These platforms form the basis of our R&D and will boost our product innovation.”

Hashtag: #UniBioScienceGroup

The issuer is solely responsible for the content of this announcement.

About Uni-Bio Science Group Limited

Uni-Bio Science Group Limited is principally engaged in the research and development, manufacture and distribution of pharmaceutical products. The research and development centre is fully equipped with a complete system for the development of genetically-engineered products with a pilot plant test base which is in line with NMPA requirements. The Group also has three GMP manufacturing bases in Beijing, Dongguan and Shenzhen. The Group also has a highly efficient commercialization platform and marketing network. The Group focuses on the development of novel treatments and innovative drugs addressing the therapeutic areas of endocrine such as diabetes and osteoporosis, ophthalmology and dermatology.

Uni-Bio Science Group Limited was listed on the Main Board of the Hong Kong Stock Exchange on November 12, 2001. Stock code: 0690.

SKF’s Capital Markets Day to be held on 11 November 2025

GOTHENBURG, Sweden, Aug. 28, 2025 /PRNewswire/ — SKF welcomes institutional investors, analysts and financial media to the Group’s Capital Markets Day on 11 November. During the event, participants will have the opportunity to gain deeper insights into the strategic direction of both the Industrial and the Automotive businesses post the planned separation of Automotive from the SKF Group, and how value is unlocked by being two standalone businesses.

Speakers on the Capital Markets Day will include President and CEO Rickard Gustafson as well as other members of Group Management. They will provide insights on the long-term value creation that the Automotive separation facilitates, including:

  • For the Industrial business: a clearer focus on distinct opportunities in targeted markets leveraging megatrends to enhance customer value and accelerate profitable growth.
  • For the Automotive business: reviewing market conditions and drivers and exemplifying how independent decision-making enables the speedy actions needed to adapt to a transforming, global automotive market, while also managing cost.

In addition, financial targets for the SKF Group post separation of the Automotive, i.e. the Industrial business, will be presented at the event. For the Automotive business, indicative financial objectives will be shared.

“We look forward to meet investors, analysts and media in November and present the progress in building two standalone businesses and how this will create even stronger Industrial and Automotive businesses,” says Rickard Gustafson, President and CEO.

Participants are welcome to attend in person at At Six, Brunkebergstorg 6 in Stockholm, Sweden. The Capital Markets Day, which will be held in English, will also be available online. The presentations will start at 13:00 (CET) and end around 17, followed by a mingle for those attending in person.

To participate (online or in-person), please register no later than 24 October 2025 at: https://invitepeople.com/events/fee9419f2a.

Please note that the number of participants attending in person is limited. More information on the agenda as well as logistics will be available on the registration site. For more information about SKF’s Capital Markets Day, please contact: cmd@skf.com.

Media: To book interviews with Rickard Gustafson after the event, please contact Carl Bjernstam on carl.bjernstam@skf.com.

Aktiebolaget SKF
(publ)

For further information, please contact:

Press Relations: Carl Bjernstam, +46 31-337 2517; +46 722 201 893; carl.bjernstam@skf.com 

Investor Relations: Sophie Arnius, +46 31-337 8072; +46 705 908072; sophie.arnius@skf.com 

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/skf/r/skf-s-capital-markets-day-to-be-held-on-11-november-2025,c4225638

The following files are available for download:

https://mb.cision.com/Main/637/4225638/3633288.pdf

20250828 SKF’s Capital Markets Day to be held on 11 November 2025

https://news.cision.com/skf/i/0901d196808e8d97-jpeg-fullresolution,c3464420

0901d196808e8d97 jpeg fullresolution

https://news.cision.com/skf/i/skf–47a6381-2,c3464419

SKF- 47A6381 2

 

Jinchang Power Supply Company’s “Electricity Stewards” Offer On-Site Solutions to Solve Enterprise Challenges

JINCHANG, China, Aug. 28, 2025 /PRNewswire/ — Recently, Shi Weilong and Liu Xuebin, staff members of State Grid Jinchang Power Supply Company, visited Jinchang Baye Hengtong Concrete Co., Ltd. to conduct electrical equipment inspection and energy efficiency diagnosis services. They thoughtfully reminded the enterprise manager: “Please check the distribution room regularly and pay close attention to the transformer operating status. Feel free to contact us with any electricity usage issues.”

Sun Jun, General Manager of Jinchang Baye Hengtong Concrete Co., Ltd., said that he now checks the enterprise’s electricity consumption analysis on the “State Grid Online” app every day. “Look at this electricity cost trend chart,” he said with a smile. “The average monthly electricity bill is now over 10,000 yuan less than before! The service from the power supply company truly hits the mark for us.”

When Shi Weilong and Liu Xuebin first visited in late autumn last year, Sun Jun was puzzled over a stack of electricity bills. The bills showed a “power factor of 0.75,” indicating inefficient electricity usage that incurred high monthly penalty fees, yet the equipment seemed to be running normally, and the root cause remained elusive.

Instead of jumping to conclusions, Liu Xuebin went directly to the production workshop and used an infrared thermometer to scan each motor one by one. Subsequently, with the cooperation of the plant electrician, they entered the distribution room for a detailed inspection. The diagnosis revealed severe oxidation of the capacitor cabinet contactor points, causing slow response, excessive no-load current in three motors, and the capacitor capacity had nearly halved. Liu Xuebin explained vividly: “The equipment’s electricity consumption fluctuates greatly, and the capacitor cabinet can’t adjust in time, just like a person breathing unevenly—it’s inevitably more strenuous.”

The next day, Shi Weilong and Liu Xuebin returned with a transformation plan. Addressing the enterprise’s concerns about affecting production, they clearly stated: “We will work during nighttime production breaks, running wiring during the day and replacing the cabinet after midnight, ensuring no disruption to normal production.” The capacitor cabinet upgrade was completed smoothly in just three days.

A month later, the electricity bill showed the power factor had improved to 0.98, reducing electricity costs by 18,000 yuan compared to the previous period. The company accountant excitedly ran into the workshop with the bill to share the news. Sun Jun repeatedly verified the data and exclaimed happily: “What we save is what we earn! The power supply company are truly our ‘Electricity Stewards’!”

This initiative is a snapshot of State Grid Jinchang Power Supply Company’s ongoing efforts to optimize the power business environment and promote service quality and efficiency. By offering proactive visits, energy efficiency diagnoses, and technical upgrades, the company helps enterprises reduce costs and increase efficiency, providing robust support for high-quality electricity usage.